Teva Pharmaceutical Finance Netherlands IV BV

CUSIP: 881937AA4 Class: Corporate Bond - Foreign US$

Holders for Q4 2025 Position Changes for Q4 2025

Note: Option positions (PUT/CALL) are excluded.

Increased Positions (1)

Pacer Advisors, Inc.
Value ($000) $78 (+17.8%) Shares 75,000 (+17.2%)